搜索临床试验以:Xenograft rejection
总计929个结果
-
Imperial College LondonCambridge University Hospitals NHS Foundation Trust; National Institute for Health Research,... 和其他合作者主动,不招人
-
Integra LifeSciences CorporationVanderbilt University Medical Center撤销
-
Medical College of WisconsinNational Heart, Lung, and Blood Institute (NHLBI); University of California, Los Angeles; Columbia... 和其他合作者完全的
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna完全的
-
Assistance Publique - Hôpitaux de ParisCSL Behring; Association ASLUMARE完全的
-
Medical University of WarsawMinistry of Science and Higher Education, Poland主动,不招人
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
Vastra Gotaland Region完全的
-
Paris Translational Research Center for Organ Transplantation未知免疫抑制 | 肾移植失败和排斥 | 药效延长 | 嫁接损失
-
Prof. Dr. Petra ReinkeInstitut Klinické a Experimentální Medicíny完全的
-
Columbia UniversityVeloxis Pharmaceuticals主动,不招人
-
Medical University of GrazJohannes Kepler University of Linz; Fresenius Kabi Austria GmbH, Graz完全的
-
Heidelberg University未知
-
ORIOL BESTARDDepartment of Health, Generalitat de Catalunya未知
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals终止肾移植西班牙, 德国, 瑞士, 意大利, 英国, 法国, 美国, 加拿大
-
Novartis Pharmaceuticals完全的
-
The Methodist Hospital Research InstituteVeloxis Pharmaceuticals撤销肾移植急性排斥反应 | 肾脏疾病,终末期 | 供体特异性抗体
-
University of Colorado, Denver终止
-
Stony Brook UniversityNational Institute of Mental Health (NIMH); University of Michigan完全的
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)终止
-
Leiden University Medical Center未知
-
Assistance Publique - Hôpitaux de ParisFondation Centaure完全的
-
Medical University of ViennaCharite University, Berlin, Germany; University of Alberta; CSL Behring完全的
-
University of AarhusNovo Nordisk A/S邀请报名
-
Washington University School of MedicineNovartis Pharmaceuticals终止